Companies dealing in life sciences and technology face tougher times ahead due to global economic uncertainty and political crisis at home

US company Eli Lilly says 100,000 doses of its monoclonal treatment 'ready immediately' for distribution to high-risk patients aged 12 and older

Eli Lilly says phase 3 trial shows combination of two synthetic antibodies has ‘potential to be an important treatment in high-risk patients’

As states, localities tussle over terms of agreement, pharmaceutical firms say they're unwilling to top initial $48 billion offer

Herzliya- and San Francisco-based company with ties to medical giant Teva developing drug to treat NASH, a severe liver disease

Figures show Israeli pharmaceutical giant produced less than 1% of the 76 billion oxycodone and hydrocodone pills; Sackler-owned Purdue produced about 3% in 2006-2012

Drug company used Italian doctor, apparently employing practices that helped create US addiction crisis that has claimed 400,000 lives